openPR Logo
Press release

Monteranc Cosmetics in Gangnam District: The Secret Behind Captivating the Global Wealthy

03-26-2024 02:46 AM CET | Associations & Organizations

Press release from: ABNewswire

Monteranc Cosmetics in Gangnam District: The Secret Behind

Monteranc has become a buzzworthy beauty brand in Korea, mainly known for its baby face serum in the Gangnam District. Gangnam is renowned for being home to the country's wealthiest residents. Monteranc's best-selling Volumefilling Serum initially had over 90% of its buyers residing in Gangnam, showcasing the brand's growth through word-of-mouth popularity within this affluent area. Although its market share in Gangnam has slightly decreased as the brand gained nationwide popularity, Gangnam still leads in sales volume, reflecting the ongoing love for Monteranc among its residents.

This trend continues even after the brand has expanded globally. Following its launch in China last December, the brand quickly became a topic of conversation among the wealthy in big cities like Shanghai and Beijing, with most customers from China's affluent class.

A Monteranc representative commented on this phenomenon: "Even though we don't specifically focus on luxury marketing, our product quality seems to naturally attract word-of-mouth in regions with high purchasing power where residents have experienced various high-quality products."

Indeed, Monteranc is a brand that prioritizes product quality over marketing.

One or two unique ingredients are usually only found in luxury cosmetics, but the Volumefilling Serum contains over 80 of them, so it is not the cheapest option. However, despite several upgrades, the price of the Volumefilling Serum has remained the same as it was ten years ago. The Monteranc representative added, "We will continue to invest a significant portion of our profits into improving product quality and strive to offer products with high-quality ingredients at reasonable prices to many people."

Monteranc's Global Mall (https://www.monteranc.com [https://www.monteranc.com/]) is available from March 2024 in the United States, where it has become popular among wealthy women.

Media Contact
Company Name: Almerson Pacific
Contact Person: Taehwan Kim
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=monteranc-cosmetics-in-gangnam-district-the-secret-behind-captivating-the-global-wealthy]
Country: South Korea
Website: https://monteranc.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monteranc Cosmetics in Gangnam District: The Secret Behind Captivating the Global Wealthy here

News-ID: 3441714 • Views:

More Releases from ABNewswire

California Libraries Now Offer Free Ecosense EcoBlu Radon Monitors Through CDPH Program
California Libraries Now Offer Free Ecosense EcoBlu Radon Monitors Through CDPH …
A new statewide initiative expands radon awareness and provides residents with free, easy-to-use digital testing devices. Ecosense [https://ecosense.io/] announced its partnership with the California Department of Public Health (CDPH) Indoor Radon Program [https://www.cdph.ca.gov/Programs/CEH/DRSEM/Pages/EMB/Radon/Radon.aspx] to provide digital radon detection technology to all residents throughout the state. Through the U.S. Environmental Protection Agency's State Indoor Radon Grant (SIRG), CDPH acquired 600 Ecosense EcoBlu digital radon monitors, now deployed across 21 public library systems
Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Ch …
DelveInsight's "Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest
Wiskott-Aldrich Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight
Wiskott-Aldrich Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving …
DelveInsight's "Wiskott-Aldrich Syndrome Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Wiskott-Aldrich Syndrome pipeline landscape. It covers the Wiskott-Aldrich Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wiskott-Aldrich Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment
Dilated Cardiomyopathy Treatment Pipeline Shows Strong Momentum as 8+ Pharma Companies in the Race | DelveInsight
Dilated Cardiomyopathy Treatment Pipeline Shows Strong Momentum as 8+ Pharma Com …
DelveInsight's "Dilated Cardiomyopathy Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Dilated Cardiomyopathy pipeline landscape. It covers the Dilated Cardiomyopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dilated Cardiomyopathy therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment

All 5 Releases